Home › Research › Treatments
Effect of cerebellum stimulation on cognitive recovery in patients with Alzheimer disease: A randomized clinical trial
Yao Q, Tang F, Wang Y, Yan Y, Dong L, Wang T, Zhu D, Tian M et al.. Brain stimulation, 2022-06-11
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Introduction Evidence indicates that the cerebellum is involved in cognitive processing. However, the specific mechanisms through which the cerebellum repetitive transcranial magnetic stimulation (rTMS) contributes to the cognitive state are unclear. Methods In the current randomized, double-blind, sham-controlled trial, 27 patients with Alzheimer's disease (AD) were randomly allotted to one of the two groups: rTMS-real or rTMS-sham. We investigated the efficacy of a four-week treatment of bilateral cerebellum rTMS to promote cognitive recovery and alter specific cerebello-cerebral functional connectivity. Results The cerebellum rTMS significantly improves multi-domain cognitive functions, directly associated with the observed intrinsic functional connectivity between the cerebellum nodes and the dorsolateral prefrontal cortex (DLPFC), medial frontal cortex, and the cingulate cortex in the real rTMS group. In contrast, the sham stimulation showed no significant impact on the clinical improvements and the cerebello-cerebral connectivity. Conclusion Our results depict that 5 Hz rTMS of the bilateral cerebellum is a promising, non-invasive treatment of cognitive dysfunction in AD patients. This cognitive improvement is accompanied by brain connectivity modulation and is consistent with the pathophysiological brain disconnection model in AD patients.
What this study adds
Evidence grade: High
This is a trial of 27 participants. The authors describe this as a promising non-invasive treatment of cognitive dysfunction in AD patients, but the sample was small.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Yao, Q., Tang, F., Wang, Y., Yan, Y., Dong, L., Wang, T., et al. (2022). Effect of cerebellum stimulation on cognitive recovery in patients with Alzheimer disease: A randomized clinical trial. Brain stimulation. https://doi.org/10.1016/j.brs.2022.06.004
Vancouver
Yao Q, Tang F, Wang Y, Yan Y, Dong L, Wang T, et al. Effect of cerebellum stimulation on cognitive recovery in patients with Alzheimer disease: A randomized clinical trial. Brain stimulation. 2022. doi:10.1016/j.brs.2022.06.004. PMID: 35700915.
BibTeX
@article{yao2022-35700915,
author = {Yao, Q. and Tang, F. and Wang, Y. and Yan, Y. and Dong, L. and Wang, T. and Zhu, D. and Tian, M. and others},
title = {{Effect of cerebellum stimulation on cognitive recovery in patients with Alzheimer disease: A randomized clinical trial}},
journal = {Brain stimulation},
year = {2022},
doi = {10.1016/j.brs.2022.06.004},
pmid = {35700915},
url = {https://doi.org/10.1016/j.brs.2022.06.004}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- Introduction Evidence indicates that the cerebellum is involved in cognitive processing.
- Results The cerebellum rTMS significantly improves multi-domain cognitive functions, directly associated with the observed intrinsic functional connectivity between the cerebellum nodes and the dorsolateral prefrontal cortex (DLPFC), medial frontal cortex, and the cingulate cortex in the real rTMS group.
- In contrast, the sham stimulation showed no significant impact on the clinical improvements and the cerebello-cerebral connectivity.
- Conclusion Our results depict that 5 Hz rTMS of the bilateral cerebellum is a promising, non-invasive treatment of cognitive dysfunction in AD patients.
Why it matters
In this randomized, double-blind, sham-controlled trial of 27 patients with Alzheimer disease, four weeks of bilateral cerebellum repetitive transcranial magnetic stimulation significantly improved multi-domain cognitive functions, while sham stimulation showed no significant impact. The authors describe this as a promising non-invasive treatment of cognitive dysfunction in AD patients, but the sample was small.
New to this subject? Start with our plain-English guide: Treatments →
Study details
- Participants27
- Evidence strengthHigh
How this study scored 61/100
Published in a peer-reviewed journal, and it is a randomized controlled trial. Scored zero for effect reported because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Brain stimulation) |
| Journal's citation record | 1 / 4 | Brain stimulation: journal h-index 148 (OpenAlex, 2026-10-29) |
| Study design | 11 / 12 | A randomized controlled trial (from PubMed type “Randomized Controlled Trial”) |
| Strength of evidence | 5 / 5 | Rated “high” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 3 / 5 | 2022 — within 6 year(s) of the newest study here |
| Sample size | 1 / 4 | 27 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 2 / 2 | Randomized and blinded or placebo-controlled (as stated in the record) |
| Times cited | 4 / 7 | Cited 98 times (OpenAlex, 2026-10-10) |
| Citations per year | 3 / 5 | 16.3 citations a year over 6 year(s) since 2022 |
| Impact for its field and year | 3 / 6 | Cited 5.2× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 3 / 4 | Cited 83 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Jingping Shi: h-index 25 (OpenAlex, whole career) |
| Institution's track record | 0 / 3 | Nanjing Medical University: institution h-index 508 (OpenAlex) |
| Multicenter collaboration | 1 / 3 | OpenAlex lists 3 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 35700915) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Total | 61 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1016/j.brs.2022.06.004
- PubMed: 35700915
- Original source →
- Free full text: brainstimjrnl.com →
Full text: free to read — Unpaywall lists this copy as free to read: the link above (checked 10 Oct 2026).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Related studies in Treatments from nearby years
Also tagged “trial”
783 studies in the library carry the topic tag “trial”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 783 tagged studies.